This is a Validated Antibody Database (VAD) review about rat Hdac9, based on 6 published articles (read how Labome selects the articles), using Hdac9 antibody in all methods. It is aimed to help Labome visitors find the most suited Hdac9 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Hdac9 synonym: RGD1310748; RGD1563092
Abcam
domestic rabbit monoclonal (EPR5223) |
| Abcam Hdac9 antibody (Abcam, EPR5223) was used in immunohistochemistry on human samples (fig 6a). J Immunother Cancer (2020) ncbi |
domestic rabbit monoclonal (EPR5223) |
| In order to research the role of HDAC9 in regulating kidney angiotensinogen expression, Abcam Hdac9 antibody (Abcam, ab109446) was used in chromatin immunoprecipitation on rat samples (fig 7a), in immunocytochemistry on rat samples (fig 5b) and in western blot on rat samples (fig 5a). Biol Sex Differ (2017) ncbi |
domestic rabbit monoclonal (EPR5223) |
| Abcam Hdac9 antibody (Abcam, ab109446) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 6b). Eur J Vasc Endovasc Surg (2017) ncbi |
Santa Cruz Biotechnology
mouse monoclonal |
| Santa Cruz Biotechnology Hdac9 antibody (Santa Cruz, sc-398003) was used in immunohistochemistry - frozen section on human samples at 1:20 (fig 1i). Nat Commun (2018) ncbi |
mouse monoclonal |
| Santa Cruz Biotechnology Hdac9 antibody (Santa cruz, Sc398003) was used in western blot on human samples (fig 4c). Cancer Invest (2017) ncbi |
mouse monoclonal |
| Santa Cruz Biotechnology Hdac9 antibody (Santa Cruz, sc-398003) was used in immunohistochemistry - frozen section on human samples (fig 5a) and in western blot on human samples (fig 2d). Mol Cell Biochem (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments